Bridget Bagert

558 total citations
11 papers, 330 citations indexed

About

Bridget Bagert is a scholar working on Pathology and Forensic Medicine, Neurology and Neurology. According to data from OpenAlex, Bridget Bagert has authored 11 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 3 papers in Neurology. Recurrent topics in Bridget Bagert's work include Multiple Sclerosis Research Studies (5 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Lanthanide and Transition Metal Complexes (1 paper). Bridget Bagert is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Lanthanide and Transition Metal Complexes (1 paper). Bridget Bagert collaborates with scholars based in United States and Australia. Bridget Bagert's co-authors include Dennis Bourdette, Barry Oken, Jesús Lovera, Ruth H. Whitham, Andrew Steven, K. Wild, Katherine Wild, Rachel M. Frank, Cynthia D. Morris and Shirley S. Kishiyama and has published in prestigious journals such as Neurology, Multiple Sclerosis Journal and CNS Drugs.

In The Last Decade

Bridget Bagert

9 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bridget Bagert United States	8	213	84	64	43	29	11	330
P. Scherer Germany	9	193 0.9×	104 1.2×	58 0.9×	38 0.9×	33 1.1×	12	296
S. Di Rezze Italy	11	171 0.8×	338 4.0×	54 0.8×	28 0.7×	37 1.3×	12	501
Salman Aljarallah Saudi Arabia	8	147 0.7×	77 0.9×	79 1.2×	54 1.3×	19 0.7×	31	321
Nikolaos Vlaikidis Greece	12	82 0.4×	72 0.9×	125 2.0×	72 1.7×	37 1.3×	18	423
Isabella Colonna Italy	7	62 0.3×	37 0.4×	57 0.9×	48 1.1×	10 0.3×	10	283
M Murakami Japan	6	160 0.8×	167 2.0×	45 0.7×	32 0.7×	13 0.4×	9	353
Paola Ferrigno Italy	8	98 0.5×	135 1.6×	24 0.4×	18 0.4×	25 0.9×	10	284
G. Sirabian Italy	4	347 1.6×	134 1.6×	39 0.6×	52 1.2×	70 2.4×	9	401
C. Danielle Jones United States	9	125 0.6×	37 0.4×	49 0.8×	25 0.6×	18 0.6×	20	264
Musa Öztürk Türkiye	9	105 0.5×	34 0.4×	269 4.2×	37 0.9×	19 0.7×	33	340

Countries citing papers authored by Bridget Bagert

Since Specialization

Citations

This map shows the geographic impact of Bridget Bagert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bridget Bagert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bridget Bagert more than expected).

Fields of papers citing papers by Bridget Bagert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bridget Bagert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bridget Bagert. The network helps show where Bridget Bagert may publish in the future.

Co-authorship network of co-authors of Bridget Bagert

This figure shows the co-authorship network connecting the top 25 collaborators of Bridget Bagert. A scholar is included among the top collaborators of Bridget Bagert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bridget Bagert. Bridget Bagert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Bagert, Bridget, et al.. (2023). Metronidazole Induced Encephalopathy Responsive to High Dose Thiamine (P4-12.006). Neurology. 100(17_supplement_2).

2.

Bagert, Bridget, et al.. (2022). Cefepime-induced Neurotoxicity in the Critically Ill: A Modifiable Risk Factor (P7-12.001). Neurology. 98(18_supplement).

3.

Kelley, Michael S. P., et al.. (2022). Spinal Dural Arteriovenous Fistula: The Missing-Piece Sign. Ochsner Journal. 22(1). 10–14. 4 indexed citations

4.

Steven, Andrew, et al.. (2019). Gadolinium Deposition in Neurology Clinical Practice. Ochsner Journal. 19(1). 17–25. 19 indexed citations

5.

Bagert, Bridget. (2011). Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis. Archives of Neurology. 68(11). 1379–1379. 17 indexed citations

6.

Bagert, Bridget. (2009). Epstein-barr virus in multiple sclerosis. Current Neurology and Neuroscience Reports. 9(5). 405–410. 27 indexed citations

7.

Lovera, Jesús, Bridget Bagert, Cynthia D. Morris, et al.. (2007). Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis. Multiple Sclerosis Journal. 13(3). 376–385. 63 indexed citations

8.

Oken, Barry, Kristin E. Flegal, Daniel P. Zajdel, et al.. (2006). Cognition and fatigue in multiple sclerosis: Potential effects of medications with central nervous system activity. The Journal of Rehabilitation Research and Development. 43(1). 83–83. 32 indexed citations

9.

Lovera, Jesús, Bridget Bagert, Katherine Wild, et al.. (2006). Correlations of Perceived Deficits Questionnaire of Multiple Sclerosis Quality of Life Inventory with Beck Depression Inventory and neuropsychological tests. The Journal of Rehabilitation Research and Development. 43(1). 73–73. 56 indexed citations

10.

Bagert, Bridget, et al.. (2002). Cognitive Dysfunction in Multiple Sclerosis. CNS Drugs. 16(7). 445–455. 101 indexed citations

11.

Mendez, Mario F., Bridget Bagert, & Terri Edwards-Lee. (1997). Self-injurious behavior in frontotemporal dementia. Neurocase. 3(4). 231–236. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact